IN2013MU01224A - - Google Patents
Info
- Publication number
- IN2013MU01224A IN2013MU01224A IN1224MU2013A IN2013MU01224A IN 2013MU01224 A IN2013MU01224 A IN 2013MU01224A IN 1224MU2013 A IN1224MU2013 A IN 1224MU2013A IN 2013MU01224 A IN2013MU01224 A IN 2013MU01224A
- Authority
- IN
- India
- Prior art keywords
- compositions
- sitagliptin
- metformin
- salts
- present
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides solid oral pharmaceutical compositions comprising combination of metformin and sitagliptin or salts thereof. In particular, the present invention relates to a pharmaceutical composition comprising metformin and sitagliptin or salts thereof which is devoid of any surface active agents. The invention also includes process of preparing such compositions and method of use of such compositions for treating type II diabetes.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/766,939 US20150366863A1 (en) | 2013-03-28 | 2014-03-24 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
PCT/IB2014/060081 WO2014170770A1 (en) | 2013-03-28 | 2014-03-24 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
EP14722341.6A EP2996680A1 (en) | 2013-03-28 | 2014-03-24 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
IN1224MU2013 IN2013MU01224A (en) | 2013-03-28 | 2014-03-24 | |
ZA2015/05916A ZA201505916B (en) | 2013-03-28 | 2015-08-17 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1224MU2013 IN2013MU01224A (en) | 2013-03-28 | 2014-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU01224A true IN2013MU01224A (en) | 2015-04-17 |
Family
ID=54395595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1224MU2013 IN2013MU01224A (en) | 2013-03-28 | 2014-03-24 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU01224A (en) |
-
2014
- 2014-03-24 IN IN1224MU2013 patent/IN2013MU01224A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12021550792A1 (en) | 2-(morpholin-4-yl)-1,7-naphthyridines | |
PH12016501581A1 (en) | Benzimidazol-2-amines as midh1 inhibitors | |
PH12016501807A1 (en) | Novel compounds | |
TN2017000258A1 (en) | Pyrazolopyridinamines as mknk1 and mknk2 inhibitors | |
PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
BR112017004580A2 (en) | compound, pharmaceutical composition, combination product, use of a pharmaceutically acceptable compound or salt, and method of treatment. | |
PH12016501814A1 (en) | Inhibitors of the wnt signalling pathways | |
EA033769B9 (en) | Selected amide of -hydroxybutyric acid and uses thereof in the treatment of alcohol misuse | |
EA201491581A1 (en) | ВЕЗИКУЛЯРНЫЕ КОМПОЗИЦИИ | |
GEP201706614B (en) | Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process | |
GEP20207145B (en) | Combination of trazodone and gabapentin for the treatmen | |
MX2016014261A (en) | Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis. | |
IN2013MU03428A (en) | ||
IN2013MU01224A (en) | ||
IN2013MU01222A (en) | ||
IN2013MU01225A (en) | ||
IN2013MU01223A (en) | ||
PH12015501179A1 (en) | Fixed dose pharmaceutical composition comprising mometasone and azelastine | |
MX2016003763A (en) | Laquinimod combination therapy for treatment of multiple sclerosis. | |
IN2013MU03427A (en) | ||
IN2014DN10683A (en) | ||
IN2013MU01159A (en) | ||
IN2013MU01158A (en) | ||
MA39762A (en) | Novel compounds |